Tirzepatide can feel stronger earlier for some, but long-term success depends on consistency and guided titration
The contents of this website are not intended to substitute for professional medical advice, diagnosis or treatment
While the development of glucagon-like peptide-1 receptor agonists (GLP-1RAs) has expanded diabetes care, the bulk of the literature on these medications derives from tightly controlled clinical trials (e.g., Phase III trials such as the global PIONEER program), with only a few studies investigating their real-world effectiveness
Ozempic vs Lantus and Ozempic 1 mg vs 2 mg 1 SUSTAIN 4: vs study-titrated Lantus 1,9 In insulin-nave adult patients with type 2 diabetes on metformin sulfonylurea Secondary endpoint: mean change in body weight from baseline to Week 30 Mean baseline: 206 lb SUSTAIN FORTE: Ozempic 1 mg vs 2 mg 1,4,8 In adult patients with type 2 diabetes on metformin sulfonylurea Secondary endpoint: mean change in body weight from baseline to Week 40 Mean baseline: 219 lb Results based on sensitivity analyses of retrieved dropout population
& Halin, C
Never attempt to 'salvage' a pen you suspect has degraded